Abstract 16630: Carotid Endarterectomy, Stenting, or Intensive Medical Therapy for Asymptomatic Carotid Stenosis: A Bayesian Network Meta-Analysis of Perioperative Risk and Long-Term Stroke Prevention
Karotisendarteriektomie, Stenting oder intensive medikamentöse Therapie bei asymptomatischer Karotisstenose: Bayes’sche Netzwerk-Metaanalyse zum perioperativen Risiko und zur langfristigen Schlaganfallprävention
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.16630 ↗Auf einen Blick
16 RCTs mit 16.145 Patient:innen: Best medical therapy allein war kurzfristig am sichersten, während CEA und CAS langfristig ipsilaterale Schlaganfälle reduzierten. Der Netto-Vorteil der Revaskularisation war in neueren Studien abgeschwächt.
Fragestellung
Bieten CEA oder CAS gegenüber Best medical therapy (BMT) bei asymptomatischer hochgradiger Karotisstenose einen Vorteil bei Risiko und Langzeit-Schlaganfallprävention?
Methode
Bayes’sche Netzwerk-Metaanalyse random-effects mit Markov-Chain-Monte-Carlo; RCTs zu CEA, CAS und BMT bei asymptomatischer hochgradiger Karotisstenose; Sensitivitätsanalyse für Studien ab 2000.
Ergebnisse
16 Studien mit 34 Studienarmen und 16.145 Patient:innen. 30-Tage-Schlaganfall: BMT am günstigsten, dann CEA, dann CAS. Gegen BMT höheres perioperatives Schlaganfallrisiko für CAS (OR 5,08; 95 %-KI 2,90–8,93) und CEA (OR 3,48; 95 %-KI 2,16–5,62).
Schlussfolgerung der Autor:innen
Karotisrevaskularisation ist mit einem initialen prozeduralen Schlaganfallrisiko verbunden, reduziert aber nach der perioperativen Phase ipsilaterale Schlaganfälle. In aktuellen Studien unterstützt dies intensive medikamentöse Therapie als vernünftige Primärstrategie für viele asymptomatische Patient:innen.
Kernaussagen
- BMT allein hatte die beste kurzfristige Sicherheitsbilanz.
- CEA und CAS senkten langfristig ipsilaterale Schlaganfälle.
- Der Netto-Langzeitvorteil von CEA war in aktuellen Studien abgeschwächt.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Shariq Hayat und 12 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
The question of whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) offers a net advantage over best medical therapy (BMT) alone has not been rigorously characterized across the full trial evidence base, particularly when accounting for procedural risk. Hypothesis: BMT alone confers superior short-term safety over revascularization, whereas CEA and CAS provide durable post-procedural stroke prevention; however, the net long-term benefit of revascularization is attenuated in contemporary trial cohorts.
Methods
A Bayesian network meta-analysis using random-effects models and Markov Chain Monte Carlo estimation was conducted. Randomized controlled trials evaluating a three-node network (CEA, CAS, BMT alone) for asymptomatic high-grade carotid stenosis (typically ≥60-70%) were included. Primary outcomes were 30-day perioperative stroke and long-term ipsilateral stroke. A pre-specified sensitivity analysis was restricted to trials published in 2000 or later. Analyses were performed in R version 4.6.0.
Results
Sixteen trials comprising 34 study arms and 16,145 patients were included. For 30-day stroke, BMT alone demonstrated the most favorable short-term safety profile (SUCRA 1.00), followed by CEA (SUCRA 0.47) and CAS (SUCRA 0.03). Compared with BMT alone, perioperative stroke risk was higher with CAS (OR 5.08, 95% CI 2.90-8.93) and CEA (OR 3.48, 95% CI 2.16-5.62), while CAS also carried a greater procedural risk than CEA (OR 1.46, 95% CI 1.06-2.00). During long-term follow-up, CEA demonstrated the most favorable durability profile for prevention of ipsilateral stroke (P-score 0.81), whereas CAS (P-score 0.69) and BMT alone (P-score 0.00) ranked lower. Compared with BMT alone, long-term ipsilateral stroke risk was reduced following CEA (OR 0.37, 95% CI 0.29-0.48) and CAS (OR 0.39, 95% CI 0.26-0.59). Findings were directionally consistent in analyses restricted to trials published in 2000 or later. However, when perioperative procedural events were incorporated into longitudinal outcomes, the overall long-term advantage of CEA versus BMT alone was attenuated and no longer statistically significant (OR 0.79, 95% CI 0.55-1.12), despite preservation of the post-procedural durability benefit in the contemporary cohort (OR 0.38, 95% CI 0.28-0.52).
Conclusions
Carotid revascularization is associated with an upfront procedural stroke risk but provides durable reduction in ipsilateral stroke after the perioperative period. In contemporary trial cohorts, attenuation of the net long-term benefit supports intensive medical therapy as a reasonable primary management strategy for many asymptomatic patients, particularly when procedural risk offsets downstream absolute benefit.
Zitieren
APA
Hayat, S., Khan, U., Shafi, N., Qazi, H., Ahmad, S. M., Abid, F., Sawaira, F., Nadeem, M. D., Ahmad, A., Khan, A. A., Khan, S. M., Khan, M., & Zada, A. K. (2026). Abstract 16630: Carotid Endarterectomy, Stenting, or Intensive Medical Therapy for Asymptomatic Carotid Stenosis: A Bayesian Network Meta-Analysis of Perioperative Risk and Long-Term Stroke Prevention. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.16630
Vancouver
Hayat S, Khan U, Shafi N, Qazi H, Ahmad SM, Abid F, et al. Abstract 16630: Carotid Endarterectomy, Stenting, or Intensive Medical Therapy for Asymptomatic Carotid Stenosis: A Bayesian Network Meta-Analysis of Perioperative Risk and Long-Term Stroke Prevention. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.16630
BibTeX
@article{Hayat2026,
author = {Hayat, Shariq and Khan, Umair and Shafi, Nabahat and Qazi, Hassaan and Ahmad, Syed Muhammad and Abid, Faiza and Sawaira, FNU and Nadeem, Muhammad Daniyal and Ahmad, Ayesha and Khan, AMJID ALI and Khan, Shad Muhammad and Khan, Maaz and Zada, Abdullah K},
title = {Abstract 16630: Carotid Endarterectomy, Stenting, or Intensive Medical Therapy for Asymptomatic Carotid Stenosis: A Bayesian Network Meta-Analysis of Perioperative Risk and Long-Term Stroke Prevention},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.16630}
}
EUVIMED